Related content

First-line intraperitoneal carboplatin-based chemotherapy for 165 patients with epithelial ovarian carcinoma: results of long-term follow-up

By Fujiwara K.   Sakuragi N.   Suzuki S.   Yoshida N.   Maehata K.   Nishiya M.   Koshida T.   Sawai H.   Aotani E.   Kohno I.  

Gynecologic Oncology, Vol. 90, Iss. 3, 2003-09 ,pp. : 637-643

Elsevier

Access to resources Recommend Favorite

Second-line chemotherapy in patients with primary unknown cancer

By Ono Makiko   Ando Masashi   Yonemori Kan   Yamamoto Harukaze   Hirata Taizo   Shimizu Chikako   Tamura Kenji   Katsumata Noriyuki   Fujiwara Yasuhiro  

Journal of Cancer Research and Clinical Oncology, Vol. 137, Iss. 8, 2011-08 ,pp. : 1185-1191

Springer Publishing Company

Access to resources Recommend Favorite

Taxol as Second-Line Treatment in Patients with Advanced Ovarian Cancer after Platinum-Based First-Line Chemotherapy

By Mayerhofer K.   Kucera E.   Zeisler H.   Speiser P.   Reinthaller A.   Sevelda P.  

Gynecologic Oncology, Vol. 64, Iss. 1, 1997-01 ,pp. : 109-113

Elsevier

Access to resources Recommend Favorite

Phase II study of CT-2103 in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma

By Campos Susana  

The Women's Oncology Review, Vol. 5, Iss. 2, 2005-06 ,pp. : 105-107

Informa Healthcare

Access to resources Recommend Favorite

Erratum to ''First-line intraperitoneal carboplatin-based chemotherapy for 165 patients with epithelial ovarian carcinoma: results of long-term follow-up'' - [Gynecol. Oncol. 90 (2003) 637-643]*

By Fujiwara K.   Sakuragi N.   Suzuki S.   Yoshida N.   Maehata K.   Nishiya M.   Koshida T.   Sawai H.   Aotani E.   Kohno I.  

Gynecologic Oncology, Vol. 91, Iss. 3, 2003-12 ,pp. : 662-662

Elsevier

Access to resources Recommend Favorite